Litcius/Paper detail

Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial

Seung‐Jung Park, Jung‐Min Ahn, Do‐Yoon Kang, Sung‐Cheol Yun, Youngkeun Ahn, Won‐Jang Kim, Chang‐Wook Nam, Jin‐Ok Jeong, In‐Ho Chae, Hiroki Shiomi, Hsien‐Li Kao, Joo‐Yong Hahn, Sung‐Ho Her, Bong‐Ki Lee, Tae Hoon Ahn, Kiyuk Chang, Jei Keon Chae, David Smyth, Gary S. Mintz, Gregg W. Stone, Duk‐Woo Park, Seung‐Jung Park, Jung‐Min Ahn, Do‐Yoon Kang, Sung‐Cheol Yun, Youngkeun Ahn, Won‐Jang Kim, Chang-Wook Nam Nam, Jin‐Ok Jeong, In‐Ho Chae, Hiroki Shiomi, Hsien‐Li Kao, Joo‐Yong Hahn, Sung‐Ho Her, Bong‐Ki Lee, Tae Hoon Ahn, Kiyuk Chang, Jei-Keon Chae, David Smyth, Gary S. Mintz, Gregg W. Stone, Duk‐Woo Park, Gary S. Mintz, Gregg W. Stone, Duk‐Woo Park, Duk‐Woo Park

2024The Lancet246 citationsDOI

Topics & Concepts

MedicinePercutaneous coronary interventionPopulationMyocardial infarctionInternal medicineCardiologyUnstable anginaRandomized controlled trialAcute coronary syndromeFractional flow reserveSudden cardiac deathEnvironmental healthCoronary angiographyCoronary Interventions and DiagnosticsCardiac Imaging and DiagnosticsAcute Myocardial Infarction Research